The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma: A Swedish retrospective real-world study (NEO-MEL).
 
Axel Nelson
No Relationships to Disclose
 
Ellen Krabbe
No Relationships to Disclose
 
Karl Björksrtöm
No Relationships to Disclose
 
Braslav Jovanovic
No Relationships to Disclose
 
Christian Blank
Stock and Other Ownership Interests - Immagene; Signature Oncology
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GenMab (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst); Third Rock Ventures
Research Funding - 4SC (Inst); Bristol-Myers Squibb (Inst); NanoString Technologies (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - WO 2021/177822 A1
Expert Testimony - Freshfields Bruckhaus Deringer
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Gustav Ullenhag
Stock and Other Ownership Interests - Essity; Oncopeptides
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Alligator Bioscience; Bristol-Myers Squibb; Incyte; Lidds; MSD; Novartis; SeqCure Immunology
 
Hildur Helgadottir
No Relationships to Disclose
 
Lars Ny
Stock and Other Ownership Interests - SATMEG Ventures
Honoraria - Bristol-Myers Squibb; Johnson & Johnson; Leo Pharma; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Sanofi; Zealth
Research Funding - Merck (Inst); Syndax (Inst)
 
Roger Olofsson Bagge
Stock and Other Ownership Interests - SATMEG Ventures
Consulting or Advisory Role - BD Bard; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Roche
Research Funding - BMS (Inst); Endomagnetics (Inst); NeraCare GmbH (Inst); Skyline Diagnostics (Inst)